Attached files
file | filename |
---|---|
EX-31.1 - EX-31.1 - Intra-Cellular Therapies, Inc. | d18633dex311.htm |
10-Q - 10-Q - Intra-Cellular Therapies, Inc. | d18633d10q.htm |
EX-31.2 - EX-31.2 - Intra-Cellular Therapies, Inc. | d18633dex312.htm |
EX-10.1 - EX-10.1 - Intra-Cellular Therapies, Inc. | d18633dex101.htm |
Exhibit 32
CERTIFICATIONS UNDER SECTION 906
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Intra-Cellular Therapies, Inc., a Delaware corporation (the Company), does hereby certify, to such officers knowledge, that:
The Quarterly Report for the quarter ended September 30, 2020 (the Form 10-Q) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: November 9, 2020 | /s/ Sharon Mates, Ph.D. | |||
Sharon Mates, Ph.D. | ||||
Chairman, President and Chief Executive Officer | ||||
(principal executive officer) | ||||
Dated: November 9, 2020 | /s/ Lawrence J. Hineline | |||
Lawrence J. Hineline | ||||
Senior Vice President of Finance and Chief Financial Officer | ||||
(principal financial officer) |